Sangamo (SGMO) Reports Q3 Loss of $0.12, Beats by 1c
More News related to SGMO
- Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
- Sangamo (SGMO) Reports Q3 Loss of $0.12, Beats by 1c
- Sangamo BioSciences Reports Third Quarter 2009 Financial Results
- Sangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
Sangamo BioSciences (NASDAQ: SGMO) reports Q3 loss of $0.12, 1 cent better than the analyst estimate of ($0.13). Revenue for the quarter was $4.1 million, which compares to the estimate of $4.59 million.
Related Categories
EarningsStocks Mentioned
-0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
